BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Shukra Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524632
ISIN Demat
INE551C01044
Book Value (Rs)
1.4350513
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
857
P/E (TTM)
88.95
EPS (TTM)
0.22
Face Value
(Rs)
1
Back
Shukra Pharmaceuticals standalone net profit rises 35.09% in the March 2025 quarter
30-May-25   Hrs IST

Net profit of Shukra Pharmaceuticals rose 35.09% to Rs 5.39 crore in the quarter ended March 2025 as against Rs 3.99 crore during the previous quarter ended March 2024. Sales rose 21.97% to Rs 13.27 crore in the quarter ended March 2025 as against Rs 10.88 crore during the previous quarter ended March 2024.

For the full year,net profit declined 48.33% to Rs 9.58 crore in the year ended March 2025 as against Rs 18.54 crore during the previous year ended March 2024. Sales declined 56.30% to Rs 32.59 crore in the year ended March 2025 as against Rs 74.57 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales13.2710.88 22 32.5974.57 -56
OPM %55.0940.81 -39.0326.02 -
PBDT8.515.75 48 16.3421.93 -25
PBT7.575.23 45 13.3419.88 -33
NP5.393.99 35 9.5818.54 -48

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)